Emma R. Parmee

3.0k citations

36 papers · 1.8k indexed · 1 hit paper · h-index 21

Organic Chemistry top 2%
Molecular Biology top 10%
Endocrinology, Diabetes and Metabolism top 5%
Cellular and Molecular Neuroscience top 10%
Oncology

Co-authors: R. M. Garbaccio Orin Tempkin Satoru Masamune Spencer D. Dreher Richard D. Tillyer Kevin R. Campos N.K. Terrett Juan C. Alvarez
Topics: Diabetes Treatment and Management (14 papers)Receptor Mechanisms and Signaling (13 papers)Peptidase Inhibition and Analysis (6 papers)
Cited by: Organic Chemistry Endocrinology, Diabetes and Metabolism Pharmaceutical Science
Journals: Science Journal of the American Chemical Society PLoS ONE
Partner nations: United States United Kingdom Germany

In The Last Decade

Emma R. Parmee

35 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The importance of synthetic chemistry in the pharmaceutical industry

2019 454 citations Kevin R. Campos, Paul J. Coleman et al. Science profile →

Peers

Countries citing papers authored by Emma R. Parmee

Since Specialization

Citations

This map shows the geographic impact of Emma R. Parmee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma R. Parmee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma R. Parmee more than expected).

Fields of papers citing papers by Emma R. Parmee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma R. Parmee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma R. Parmee. The network helps show where Emma R. Parmee may publish in the future.

Co-authorship network of co-authors of Emma R. Parmee

This figure shows the co-authorship network connecting the top 25 collaborators of Emma R. Parmee. A scholar is included among the top collaborators of Emma R. Parmee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma R. Parmee. Emma R. Parmee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The importance of synthetic chemistry in the pharmaceutical industrybreakdown → 2019 ·Science ·Kevin R. Campos,Paul J. Coleman,Juan C. Alvarez,Spencer D. Dreher,R. M. Garbaccio,N.K. Terrett,Richard D. Tillyer,Matthew D. Truppo,Emma R. Parmee	454
2	The Impact of Chemical Probes in Drug Discovery: A Pharmaceutical Industry Perspective 2016 ·Cell chemical biology ·R. M. Garbaccio,Emma R. Parmee	57
3	A novel series of indazole-/indole-based glucagon receptor antagonists 2015 ·Bioorganic & Medicinal Chemistry Letters ·Songnian Lin,Fengqi Zhang,Guoqiang Jiang,Sajjad A. Qureshi,Xiaodong Yang,Gary G. Chicchi,Laurie Tota,Alka Bansal,Edward J. Brady,Maria E. Trujillo,Gino Salituro,Corey Miller,James R. Tata,Bei B. Zhang,Emma R. Parmee	14
4	Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice 2011 ·Diabetologia ·James Mu,Guoqiang Jiang,E.J. Brady,Qing Dallas-Yang,Fang Liu,J H Woods,Emanuel Zycband,Michael Wright,(unknown),Kai Lü,Lan Zhu,Xun Shen,Ranabir SinhaRoy,(unknown),Sajjad A. Qureshi,(unknown),Fuquan Zhang,Emma R. Parmee,(unknown)	59
5	A survey of small molecule glucagon receptor antagonists from recent patents (2006 – 2010) 2011 ·Expert Opinion on Therapeutic Patents ·Dong‐Ming Shen,Songnian Lin,Emma R. Parmee	22
6	Design and synthesis of conformationally constrained tri-substituted ureas as potent antagonists of the human glucagon receptor 2006 ·Bioorganic & Medicinal Chemistry Letters ·Rui Liang,(unknown),Edward J. Brady,Mari R. Candelore,Victor Ding,Richard Saperstein,Laurie Tota,Michael Wright,(unknown),(unknown),Sharon Tong,Song Guo Zheng,Bei B. Zhang,James R. Tata,Emma R. Parmee	16
7	Total synthesis of milbemycins: a synthesis of (6R)-6-hydroxy-3,4-dihydromilbemycin E 2005 ·Organic & Biomolecular Chemistry ·Madeleine Helliwell,(unknown),Emma R. Parmee,Eric J. Thomas	10
8	Direct observation (NMR) of the efficacy of glucagon receptor antagonists in murine liver expressing the human glucagon receptor 2005 ·Bioorganic & Medicinal Chemistry ·Sheila M. Cohen,Joseph Duffy,Corin O. Miller,Brian A. Kirk,Mari R. Candelore,Victor Ding,Gregory J. Kaczorowski,Laurie Tota,(unknown),Michael Wright,Emma R. Parmee,James R. Tata,Bei B. Zhang	13
9	Expression, refolding, and purification of recombinant human phosphodiesterase 3B: definition of the N-terminus of the catalytic core 2004 ·Protein Expression and Purification ·Jeffrey P. Varnerin,Caroline Chung,Sangita B. Patel,Giovanna Scapin,Emma R. Parmee,Nancy R. Morin,Douglas J. MacNeil,Doris Cully,Lex H.T. Van der Ploeg,Michael R. Tota	7
10	Hepatic glucagon receptor binding and glucose-lowering in vivo by peptidyl and non-peptidyl glucagon receptor antagonists 2004 ·European Journal of Pharmacology ·Qing Dallas-Yang,Xiaolan Shen,Mathias Z. Strowski,Edward J. Brady,Richard Saperstein,Raymond E. Gibson,Deborah Szalkowski,Sajjad A. Qureshi,Mari R. Candelore,Judith E. Fenyk-Melody,Emma R. Parmee,Bei B. Zhang,Guoqiang Jiang	31
11	Crystallization and preliminary X-ray diffraction analysis of the catalytic domain of recombinant human phosphodiesterase 3B 2003 ·Acta Crystallographica Section D Biological Crystallography ·Sangita B. Patel,Jeffrey P. Varnerin,Michael R. Tota,Scott D. Edmondson,Emma R. Parmee,Joseph W. Becker,Giovanna Scapin	2
12	4-Amino cyclohexylglycine analogues as potent dipeptidyl peptidase IV inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Emma R. Parmee,Jiafang He,Anthony Mastracchio,Scott D. Edmondson,(unknown),George J. Eiermann,William P. Feeney,Bahanu Habulihaz,Huaibing He,(unknown),Barbara Leiting,Kathryn A. Lyons,Frank Marsilio,Reshma A. Patel,Aleksandr Petrov,Jerry Di Salvo,Joseph K. Wu,Nancy A. Thornberry,Ann E. Weber	34
13	Benzyl vinylogous amide substituted aryldihydropyridazinones and aryldimethylpyrazolones as potent and selective PDE3B inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Scott D. Edmondson,Anthony Mastracchio,Jiafang He,Caroline Chung,Michael J. Forrest,(unknown),Euan MacIntyre,Joseph M. Metzger,Naphtali O’Connor,(unknown),Xinchun Tong,Michael R. Tota,Lex H.T. Van der Ploeg,(unknown),Michael H. Fisher,Matthew J. Wyvratt,Ann E. Weber,Emma R. Parmee	28
14	Human β3 adrenergic receptor agonists containing cyanoguanidine and nitroethylenediamine moieties 2001 ·Bioorganic & Medicinal Chemistry Letters ·Linda Brockunier,Mari R. Candelore,Margaret A. Cascieri,Yong Liu,Laurie Tota,Matthew J. Wyvratt,Michael H. Fisher,Ann E. Weber,Emma R. Parmee	14
15	Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human β3 adrenergic receptor agonists 2000 ·Bioorganic & Medicinal Chemistry Letters ·Emma R. Parmee,Linda Brockunier,Jiafang He,Suresh B. Singh,Mari R. Candelore,Margaret A. Cascieri,Liping Deng,Yong Liu,Laurie Tota,Matthew J. Wyvratt,Michael H. Fisher,Ann E. Weber	12
16	Human β3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides 2000 ·Bioorganic & Medicinal Chemistry Letters ·Linda Brockunier,Emma R. Parmee,Hyun Ok,Mari R. Candelore,Margaret A. Cascieri,Lawrence F. Colwell,Liping Deng,William P. Feeney,Michael J. Forrest,Gary J. Hom,D. Euan MacIntyre,Laurie Tota,Matthew J. Wyvratt,Michael H. Fisher,Ann E. Weber	179
17	Human β3 andrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides 1999 ·Bioorganic & Medicinal Chemistry Letters ·Elizabeth M. Naylor,Emma R. Parmee,Vincent J. Colandrea,(unknown),Linda Brockunier,Mari R. Candelore,Margaret A. Cascieri,Lawrence F. Colwell,Liping Deng,William P. Feeney,Michael J. Forrest,Gary J. Hom,D. Euan MacIntyre,Catherine D. Strader,Laurie Tota,Pei-Ran Wang,Matthew J. Wyvratt,Michael H. Fisher,Ann E. Weber	37
18	Human β3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamides 1999 ·Bioorganic & Medicinal Chemistry Letters ·Emma R. Parmee,Elizabeth M. Naylor,(unknown),Vincent J. Colandrea,Hyun Ok,Mari R. Candelore,Margaret A. Cascieri,Liping Deng,William P. Feeney,Michael J. Forrest,Gary J. Hom,D. Euan MacIntyre,Randall R. Miller,Ralph A. Stearns,Catherine D. Strader,Laurie Tota,Matthew J. Wyvratt,Michael H. Fisher,Ann E. Weber	25
19	The catalytic asymmetric aldol reaction of aldehydes with unsubstituted and monosubstituted silyl ketene acetals: formation of anti-β-hydroxy-α-methyl esters 1992 ·Tetrahedron Letters ·Emma R. Parmee,Yaping Hong,Orin Tempkin,Satoru Masamune	74
20	Milbemycin synthesis: synthesis of 6β-hydroxy-3,4-dihydromilbemycin E 1991 ·Tetrahedron Letters ·(unknown),Emma R. Parmee,Eric J. Thomas	13

About Emma R. Parmee

Emma R. Parmee is a scholar working on Endocrinology, Diabetes and Metabolism, Animal Science and Zoology and Organic Chemistry, having authored 36 papers that have together received 1.8k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (14 papers), Receptor Mechanisms and Signaling (13 papers) and Peptidase Inhibition and Analysis (6 papers). The work is most often cited by research in Organic Chemistry (1.0k citations), Endocrinology, Diabetes and Metabolism (317 citations) and Pharmaceutical Science (93 citations). Emma R. Parmee has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include R. M. Garbaccio, Orin Tempkin, Satoru Masamune, Spencer D. Dreher, Richard D. Tillyer, Kevin R. Campos, N.K. Terrett, Juan C. Alvarez, Matthew D. Truppo and Paul J. Coleman. Their work appears in journals such as Science, Journal of the American Chemical Society and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact